Oridion Systems Ltd.

www.oridion.com

Now Medtronic Israel

High-Tech Company

Acquired by Covidien

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Revenue Growth
Established	1987
Number of Employees	135
Reg. Number:	abCDe

DESCRIPTION

Oridion is a global medical device company with patented technologies using breath samples in respiratory care monitoring and point-of-care diagnostics for both acute and non-acute settings. Oridion operates two business units: The Capnography Business Unit promotes the enhancement of patient safety monitoring by developing proprietary medical devices and consumables for the measurement of carbon dioxide in human breath. Oridion’s capnography products determine the status and adequacy of a patient’s ventilation in all patient environments; The Breath Testing Business Unit develops proprietary medical devices and consumables used in the non-invasive diagnosis of the status of a patient’s internal organs. Oridion’s Breath Testing device enables the physician to diagnose and prescribe treatment for patients in a single office visit.

TECHNOLOGY

Oridion's core technology, Microstream(R), is based on molecular correlation spectroscopy (MCS(TM)).
Oridion uses a laser-based technology - Molecular Correlation Spectroscopy™ (MCS™) to increase the accuracy and reliability of capnography monitoring. With lock and key precision, MCS creates an infrared emission that precisely matches the absorption spectrum of CO2.
Smart Capnography is a family of superior algorithms that reduce alarms, improve workflow and provide clinical utility for improved patient safety. Today, Smart Capnography includes the Smart Breath Detection Algorithm™ (Smart BDA™), Smart Alarm for Respiratory Analysis (SARA™) and the Integrated Pulmonary Index™ (IPI).

Products and Phases

Product	Phase
CapnostreamTM20	FDA Approved CE Approved
CapnostreamTM20 is a breathing monitor, which presents the company's innovative IPI - Integrated Pulmonary Index.
EtCO2	FDA Approved CE Approved
Breath sampling circuits
Microstream	FDA Approved CE Approved
Microstream capnography delivers effective, proven airway management by providing the earliest indication of airway compromise.The superior technology of Microstream® handheld and bedside capnographs, provides an accurate, reliable and easy to use assessment of your patient’s breathing quality, whether intubated or non-intubated, in any clinical setting.

ESTIMATED ANNUAL SALES

Year	Amount
2011	500
2010	490
2009	480
2008	470
2007	460
2006	450
2005	440
2004	430
2003	420
2002	410
2001	400

	TARGET MARKETS
	Medical Device Companies, Health Care Services Providers.

	BUSINESS MODEL
	B2B

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm
abC Defghij	Accounting Firm

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

Address	7 Hamarpe St., Bldg. 5, Har-Hotzvim
POB	45025
City	Jerusalem
Country	Israel
Zip	91450

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Needham, United States

Address	160 Gould St., Suite 205
City	Needham
State/Province	MA
Country	United States
Zip	02494

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Tokyo, Japan

Address	Meguro Central Plaza, Bldg #301, 6-1-20 Himonya Meguro-ku
City	Tokyo
Country	Japan
Zip	152-0003

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Yacov Bubis	Co-Founder	Medtronic Israel (VP, Global OEM Solutions, Patient Monitoring)
Mr. Uri Gal	Global VP, Human Resources
Mr. Dominic Corsale	VP, Business Development
Mr. Thomas Millonig	Global VP, Sales & Marketing
Ms. Edna Wellner	VP, Quality Assurance
Ms. Elena Gerberg	Investor Relations Manager
Mr. George Yariv	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Independent Hospital & Health Care Professional
abC Defghij	Board Member	Former President, Israel Institute of Technology
abC Defghij	External Director	General Manager, Orex

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Apr. 05, 2012

abCDe

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Feb. 25, 2001	Second Public Offering	SWX	abCDe	abCDe	Swiss Exchange
Apr. 10, 2000	IPO	SWX	abCDe	abCDe	Swiss Exchange

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Mezzanine

Jun. 01, 1998

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Bank	abCDe

Third Round

May. 01, 1996

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Holding Company	abCDe	Sold its holdings in the company for $10m

Second Round

Nov. 01, 1994

R&D

abCDe

First Round

Jan. 01, 1992

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

	PORTFOLIO COMPANIES

Exits (2)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	19/02/2020	abCDe	NIS 169m
abC Defghij	IPO	06/06/2007	abCDe	Former ticker was BRTD 05/2020: Delisted from TASE following acquisition by Meridian Bioscience.

Last Updated:	abCDe
IVC Number:	abCDe